AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
ANTI-GLYCOPROTEIN IB CAUSES PLATELET-AGGREGATION - DIFFERENT EFFECTS OF BLOCKING GLYCOPROTEIN IB AND GLYCOPROTEIN IIB IIIA IN THE HIGH-SHEAR FILTEROMETER/
Authors: OBRIEN JR ETHERINGTON MD
Citation: Jr. Obrien et Md. Etherington, ANTI-GLYCOPROTEIN IB CAUSES PLATELET-AGGREGATION - DIFFERENT EFFECTS OF BLOCKING GLYCOPROTEIN IB AND GLYCOPROTEIN IIB IIIA IN THE HIGH-SHEAR FILTEROMETER/, Blood coagulation & fibrinolysis, 9(6), 1998, pp. 453-461
SUPERCONDUCTIVITY THROUGH REDOX TREATMENTS OF (Y1-ZCAZ)SR-2(CU1-XFEX)(3)O-Y
Authors: OBRIEN JR OESTERREICHER H
Citation: Jr. Obrien et H. Oesterreicher, SUPERCONDUCTIVITY THROUGH REDOX TREATMENTS OF (Y1-ZCAZ)SR-2(CU1-XFEX)(3)O-Y, Superconductor science and technology, 11(1), 1998, pp. 162-164
CELL-VOLUME EXPANDED ERBA2CU3OY NEAR Y=6.5 THROUGH GETTER ANNEALING
Authors: OBRIEN JR OESTERREICHER H
Citation: Jr. Obrien et H. Oesterreicher, CELL-VOLUME EXPANDED ERBA2CU3OY NEAR Y=6.5 THROUGH GETTER ANNEALING, Journal of alloys and compounds, 267(1-2), 1998, pp. 70-75
PLATELETS, ASPIRIN, AND CARDIOVASCULAR-DISEASE
Authors: ELWOOD PC HUGHES C OBRIEN JR
Citation: Pc. Elwood et al., PLATELETS, ASPIRIN, AND CARDIOVASCULAR-DISEASE, Postgraduate medical journal, 74(876), 1998, pp. 587-591
NEW-TYPE OF ORTHORHOMBICITY AND CELL-VOLUME EXPANSIONS NEAR HALF FILLING OF O INTERCALATION IN ERBA2CU3O6-CENTER-DOT-5
Authors: OBRIEN JR OESTERREICHER H
Citation: Jr. Obrien et H. Oesterreicher, NEW-TYPE OF ORTHORHOMBICITY AND CELL-VOLUME EXPANSIONS NEAR HALF FILLING OF O INTERCALATION IN ERBA2CU3O6-CENTER-DOT-5, Journal of solid state chemistry, 135(2), 1998, pp. 307-311
THE RELATIVE POWER OF HEAT-PRECIPITATION NEPHELOMETRIC AND CLOTTABLE (CLAUSS) FIBRINOGEN IN THE PREDICTION OF ISCHEMIC-HEART-DISEASE - THE CAERPHILLY AND SPEEDWELL STUDIES
Authors: SWEETNAM PM YARNELL JWG LOWE GDO BAKER IA OBRIEN JR RUMLEY A ETHERINGTON MD WHITEHEAD PJ ELWOOD PC
Citation: Pm. Sweetnam et al., THE RELATIVE POWER OF HEAT-PRECIPITATION NEPHELOMETRIC AND CLOTTABLE (CLAUSS) FIBRINOGEN IN THE PREDICTION OF ISCHEMIC-HEART-DISEASE - THE CAERPHILLY AND SPEEDWELL STUDIES, British Journal of Haematology, 100(3), 1998, pp. 582-588
CALCIUM DEPRIVATION FOR 24 HOURS BLOCKS PLATELET GPIIB IIIA ACTIVATION BUT GPIB IS APPARENTLY UNAFFECTED/
Authors: OBRIEN JR ETHERINGTON MD
Citation: Jr. Obrien et Md. Etherington, CALCIUM DEPRIVATION FOR 24 HOURS BLOCKS PLATELET GPIIB IIIA ACTIVATION BUT GPIB IS APPARENTLY UNAFFECTED/, Thrombosis and haemostasis, 1997, pp. 1951-1951
THE ANTIGENIC ASSAY OF VWF MAY NOT REFLECT FUNCTIONAL-ACTIVITY - CLINICAL AND MOLECULAR SIGNIFICANCE
Authors: OBRIEN JR ETHERINGTON MD
Citation: Jr. Obrien et Md. Etherington, THE ANTIGENIC ASSAY OF VWF MAY NOT REFLECT FUNCTIONAL-ACTIVITY - CLINICAL AND MOLECULAR SIGNIFICANCE, Thrombosis and haemostasis, 1997, pp. 2584-2584
THE ENDOTHELIAL VON-WILLEBRAND-FACTOR IN VENOUS OCCLUSION BLOOD
Authors: OBRIEN JR ETHERINGTON MD
Citation: Jr. Obrien et Md. Etherington, THE ENDOTHELIAL VON-WILLEBRAND-FACTOR IN VENOUS OCCLUSION BLOOD, Thrombosis and haemostasis, 78(6), 1997, pp. 1528-1529
SENSITIVITY OF AEROBIC SPORE-FORMING SPECIES OF THE GENUS BACILLUS TOTHE PTERIDINE COMPOUND O129
Authors: OBRIEN JR GEORGE NM
Citation: Jr. Obrien et Nm. George, SENSITIVITY OF AEROBIC SPORE-FORMING SPECIES OF THE GENUS BACILLUS TOTHE PTERIDINE COMPOUND O129, Microbios, 90(363), 1997, pp. 71-78
NEW DIRECTIONS IN ANTICOAGULANT AND ANTIPLATELET TREATMENT
Authors: OBRIEN JR
Citation: Jr. Obrien, NEW DIRECTIONS IN ANTICOAGULANT AND ANTIPLATELET TREATMENT, HEART, 75(4), 1996, pp. 426-426
HIGH SHEAR-INDUCED PLATELET ACTIVATION AND INACTIVATION - THE IMPORTANCE OF METHODOLOGY
Authors: OBRIEN JR ETHERINGTON MD
Citation: Jr. Obrien et Md. Etherington, HIGH SHEAR-INDUCED PLATELET ACTIVATION AND INACTIVATION - THE IMPORTANCE OF METHODOLOGY, Blood coagulation & fibrinolysis, 7(2), 1996, pp. 228-232
ANGIODYSPLASIA, HEMOSTASIS AND CAPILLARIES - A HYPOTHESIS
Authors: OBRIEN JR
Citation: Jr. Obrien, ANGIODYSPLASIA, HEMOSTASIS AND CAPILLARIES - A HYPOTHESIS, Thrombosis research, 84(5), 1996, pp. 385-387
20 MINUTES OF VENOUS OCCLUSION - PURPURA AFTER RELEASE
Authors: OBRIEN JR
Citation: Jr. Obrien, 20 MINUTES OF VENOUS OCCLUSION - PURPURA AFTER RELEASE, Microvascular research, 52(3), 1996, pp. 293-293
TRANSITIONS FROM DOLE TO PRESUMED ELECTRON DOPING IN 123 CUPRATES
Authors: OBRIEN JR OESTERREICHER H
Citation: Jr. Obrien et H. Oesterreicher, TRANSITIONS FROM DOLE TO PRESUMED ELECTRON DOPING IN 123 CUPRATES, Czechoslovak journal of Physics, 46, 1996, pp. 1199-1200
PLATELET ACTIVATION AT HIGH AND LOW SHEAR IS FOLLOWED BY INACTIVATION- THE CLINICAL RELEVANCE
Authors: OBRIEN JR
Citation: Jr. Obrien, PLATELET ACTIVATION AT HIGH AND LOW SHEAR IS FOLLOWED BY INACTIVATION- THE CLINICAL RELEVANCE, Platelets, 6(4), 1995, pp. 242-243
ACHIEVING SUPERCONDUCTIVITY THROUGH REDUCTIVE TREATMENTS OF YSR2(CU1-XFEX)(3)O-Y
Authors: OBRIEN JR OESTERREICHER H TAYLOR RD
Citation: Jr. Obrien et al., ACHIEVING SUPERCONDUCTIVITY THROUGH REDUCTIVE TREATMENTS OF YSR2(CU1-XFEX)(3)O-Y, Journal of electronic materials, 24(12), 1995, pp. 1967-1969
ANOTHER ANTITHROMBOTIC ACTION OF ASPIRIN
Authors: OBRIEN JR ETHERINGTON MD
Citation: Jr. Obrien et Md. Etherington, ANOTHER ANTITHROMBOTIC ACTION OF ASPIRIN, Thrombosis research, 80(2), 1995, pp. 185-188
DECREASED PLATELET-FUNCTION IN AORTIC-VALVE STENOSIS - HIGH-SHEAR PLATELET ACTIVATION THEN INACTIVATION
Authors: OBRIEN JR ETHERINGTON MD BRANT J WATKINS J
Citation: Jr. Obrien et al., DECREASED PLATELET-FUNCTION IN AORTIC-VALVE STENOSIS - HIGH-SHEAR PLATELET ACTIVATION THEN INACTIVATION, British Heart Journal, 74(6), 1995, pp. 641-644
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Authors: ALTMAN R CARRERAS L DIAZ R FIGUEROA E PAOLASSO E PARODI JC CADE JF DONNAN G EADIE MJ GAVAGHAN TP OSULLIVAN EF PARKIN D RENNY JTG SILAGY C VINAZZER H ZEKERT F ADRIAENSEN H BERTRANDHARDY JM BRAN M DAVID JL DRICOT J LAVENNEPARDONGE E LIMET R LOWENTHAL A MORIAU M SCHAPIRA S SMETS P SYMOENS J VERHAEGHE R VERSTRAETE M ATALLAH A BARNETT H BATISTA R BLAKELY J CAIRNS JA COTE R CROUCH J EVANS G FINDLAY JM GENT M LANGLOIS Y LECLERC J NORRIS J PINEO GF POWERS PJ ROBERTS R SCHWARTZ L SICURELLA J TAYLOR W THEROUX P TURPIE AG WEISEL RD CUI J LIU L PIRK J BAY C BOYSEN G KNUDSEN JB PETERSEN P SORENSEN PS TONNESEN HK HARJOLA PT ARCAN JC BALKAU B BLANCHARD J BOISSEL JP BONEU B BOUSSER MG BROCHIER M CLOAREC M CRIBIER G DECHAVANNE M DROUIN P ESCHWEGE E GUIRAUDCHAUMEIL B HUGONOT R LEIZOROVICZ A LORIA Y MICHAT L MIROUZE J PANAK E PASTEYER J RASCOL A REVOL L ROY M SELLES J SLAMA G STARKMAN C TEULE M THIBULT N VERRY M ALBERT FW ANDRASSY K BREDDIN K ECKEL R ENCKE A FROHLICH J HARTUNG B HEISS HW HESS H HOFLING B KRAUSE D LATTA G LINKE H LOEW D LORENZ R MIDDLETON K NOVAK G OLDENDORF M PFLUGER N RAITHEL D REUTER R SCHETTLER G SCHNITKER J SCHOOP W STIEGLER H UBERLA K VOGEL G WEBER M WELBERS I ZEITLER E ARAPAKIS G CHAN T MOK CK SZABO R MISRA NP REDDY K FITZGERALD GA APOLLONIO A BALSANO F BASELLINI A CANDELISE L CATALANO M CIAVARELLA N CIUFFETTI G COCCHERI S CORTELLARO M CORVI G COTO V DAVI G DECATERINA R DIPERRI T FIESCHI C GENTILE R GREGORATTI L GRESELE P LAVEZZARI M LIBRETTI A MAGNANI B NENCI G PAGANO G PATRONO C PEDRINI L PINI M PRANDONI P ROMEO F ROVELLI F RUDELLI G RUVOLO G SIGNORINI GP TOGNONI G VIOLI F FUJIMORI T KAGEYAMA M KATSUMURA T KITAMURA S MAEDA K SUZUKI A TOHGI H UCHIYAMA S UTSUMI H GARCIA AM ALGRA A DENOTTOLANDER GJH KUPPER AJF VANGIJN J HART H KAPPELLE LJ KOUDSTAAL PJ LEMMENS T LODDER J PANNEBAKKER M SERRUYS PW VANDENBELT A VANDERMEER J VANDERVIJGH AB VERHEUGT FWA VETH G DALE J JOHANNESSEN KA THAULOW E POPESCU P TIBERIU N AZNAR JRD ESMATJES E GUITERAS P LASIERRA J LOPEZTRIGO P ORIOL A POMAR L ROCHA E SANCHEZ FD SANCHORIEGER J SANZ G BERGLUND ULF BLOMSTRAND C BOBERG M BRITTON M ELWIN CE HELMERS C HOLM J JANZON L JUULMOLLER S MULEC H OLSSON JE PERSSON S RASMANIS G ROSEN A SAMUELSSON K SOREFF J WAHLGREN N WALLENTIN L BAUR HR BOKSLAG M BOLLINGER A MEIER B PFISTERER M PFLUGER N SITTHIAMORN C ACHESON EJ APPLEBY P ASSCHER AW AUKLAND A BAIGENT C BALA S BARNETT AH BELL P BEWS S BORN GVR BRANAGAN JP BROOKS N BROWN MJ BROWSE NL CAPILDEO R CARMALT M CARTER AE CHALMERS I CLARKE M CLARKE RJ CLYNE CAC COLLINS R COOKE ED COUTTS G COVE DH CROWTHER PS CUTHBERTSON WF DEBONO D DICKERSON C DICKINSON JP DOLL R DORMANDY JA DUNBABIN D ELL S ELPHINSTONE P ELWOOD P ENGLISHBY V FARRELL B FISKERSTRAND C FLATHER M FOLEY T FOULDS T FOX KM FRANKS P FRASER H GARDECKI T GAWEL M GENT AE GERSHLICK AH GODWIN J GOLDMAN M GRAY C GRAY D GRAY R HANDOLL H HANKEY G HARRISON MJG HENDERSON N HEPTINSTALL S HOBBIGER SF JONES EW JONES NAG JOST S JULIAN D KELLETT J KESTER RC LOWE G MACKENZIE J MCCOLLUM CN MEAD G MEADE TW MENDELOW D MILLER JC MORRIS GK NICHOL C NOBLE M OBRIEN JR OGIER M PARISH S PARRY MJ PETO R POWELL J POZZILLI P QIZILBASH N RAHMAN A RAJAH SM RICHARDS DH RICHARDS S RIPLEY R ROBERTS VC ROSE FC RUSSELL RWR RUBIN PC RUCKLEY CV SANDERCOCK P SHAW MDM SHAW KM SHELLEY JH SLATTERY J SLEIGHT P SMITH SJ STEWARTLONG P SWEETNAM PM TANSEY MJB TINDALL H TURNEY J TYLER HM VAREY NC VESSEY MP WALKER MG WALKER MA WARLOW CP WILCOX RG WILLEMS H WOOD EH WYNJONES E ADAMS HP BARTON B BEDFORD RF BICK BL BINGHAM S BROWN BG BRYANT T BURING J CABOT CF CANNER P CHESEBRO J CHRISMAN OD CLAGETT GP COLWELL JA DYKEN M ELLIS D FIELDS WS FURBERG C FUSTER V GOLDMAN S GRANETT J GREEN RM GREEN D HARDY R HARKER LA HARRIS WH HART RG HASS WK HENNEKENS C HILL D HUME M IGLOE MC JOHNSON G JONAS S KNATTERUD G KOHLER TR LEMBO NJ LEWIS D LOCKHART E MAJERUS P MCENANY MT MCKENNA R MEHTA JL MEYER JS MOLONY B MORITZ T NICOLOFF DM NYCZ G ONO H PANTELY GA PHILLIPS SJ RIDKER P ROBERTSON JT ROTHBART R SALZMAN EW SAUTTER RD SCHLANT RC SCHOENBERGER JA SENGEKONTACKET MV SHARMA G STEELE P STEINNAGEL KP STRATTON J SULLIVAN JM TIMMIS G TOOLE JF WALKER MD WEISMAN S WHITE CW WIRECKI M WOMBOLT D WONG R YUSUF S ZADINA K ZUCKER D
Citation: R. Altman et al., COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS, BMJ. British medical journal, 308(6921), 1994, pp. 81-100
SHEAR-INDUCED FILTER BLOCKAGE - A POPULATION-BASED APPRAISAL OF A METHOD FOR THE ASSESSMENT OF PLATELET, WHITE CELL AND VON-WILLEBRAND-FACTOR INTERACTIONS
Authors: BESWICK AD OBRIEN JR LIMB ES YARNELL JWG ELWOOD PC
Citation: Ad. Beswick et al., SHEAR-INDUCED FILTER BLOCKAGE - A POPULATION-BASED APPRAISAL OF A METHOD FOR THE ASSESSMENT OF PLATELET, WHITE CELL AND VON-WILLEBRAND-FACTOR INTERACTIONS, Platelets, 5(4), 1994, pp. 186-192
IDIOPATHIC CD4-LYMPHOCYTOPENIA (ICL) AMONG HIV-1 SERONEGATIVE HEMOPHILIACS AND FEMALE PARTNERS( T)
Authors: OBRIEN JR DIAMONDSTONE L GOEDERT J
Citation: Jr. Obrien et al., IDIOPATHIC CD4-LYMPHOCYTOPENIA (ICL) AMONG HIV-1 SERONEGATIVE HEMOPHILIACS AND FEMALE PARTNERS( T), AIDS research and human retroviruses, 10, 1994, pp. 190000080-190000080
HIGH SHEARING FORCES IN BLOOD - HEMOSTASIS, THROMBOSIS AND ATHEROGENESIS
Authors: OBRIEN JR
Citation: Jr. Obrien, HIGH SHEARING FORCES IN BLOOD - HEMOSTASIS, THROMBOSIS AND ATHEROGENESIS, Thrombosis research, 76(1), 1994, pp. 103-108
EFFECTS OF GETTER ANNEALING AND CODOPING OF IRON AND ZINC IN YTTRIUM-BARIUM CUPRATES
Authors: OBRIEN JR OESTERREICHER H TAYLOR RD
Citation: Jr. Obrien et al., EFFECTS OF GETTER ANNEALING AND CODOPING OF IRON AND ZINC IN YTTRIUM-BARIUM CUPRATES, Materials research bulletin, 29(9), 1994, pp. 981-985
INTERRELATIONSHIPS BETWEEN HEMOSTATIC TESTS AND THE EFFECTS OF SOME DIETARY DETERMINANTS IN THE CAERPHILLY COHORT OF OLDER MEN
Authors: ELWOOD PC BESWICK AD OBRIEN JR YARNELL JWG LAYZELL JC LIMB ES
Citation: Pc. Elwood et al., INTERRELATIONSHIPS BETWEEN HEMOSTATIC TESTS AND THE EFFECTS OF SOME DIETARY DETERMINANTS IN THE CAERPHILLY COHORT OF OLDER MEN, Blood coagulation & fibrinolysis, 4(4), 1993, pp. 529-536
Risultati: 1-25 | 26-33